Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind active and placebo-controlled trial of oxycodone/acetaminophen extended-release tablets for postoperative moderate to severe pain
CTR20250869Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone + acetaminophen in postoperative pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Mar 2025; status: completed.
02
Drugs
oxycodone + acetaminophen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20250869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250869.